WHOOP Partners with Unilabs to Launch 65-Biomarker Blood Testing in UAE

WHOOP has partnered with Unilabs to launch its Advanced Labs programme in the UAE, enabling members to access a 65-biomarker blood testing panel across the country. Under the agreement, Unilabs will offer the panel at its centres throughout the UAE, with an option for home collection.

During the initial phase, the 65-biomarker panel will be offered at a price of Dhs733, in line with pricing in the United States. After completing their tests, members can upload results to the WHOOP app, where the data is integrated with continuous metrics such as recovery, sleep, and strain to provide long-term health trend analysis.

The WHOOP Advanced Labs programme links clinically validated blood biomarkers with round-the-clock data collected from WHOOP wearables, aiming to give users a consolidated view of health indicators in one platform. The companies plan to expand the collaboration with deeper data integration over time.

Users who upload labs, including any of the 65 biomarkers, will receive personalised guidance from WHOOP Coach to contextualise results alongside recovery, sleep, and daily behaviour data.

WHOOP, founded in 2012 and headquartered in Boston, provides wearable devices, including WHOOP 5.0 and WHOOP MG. The company has raised more than $400 million in venture capital and ships to 56 markets. Its devices include features such as cardiovascular health screening with an FDA-cleared ECG, Healthspan metrics measuring the pace of ageing and WHOOP Age, and wearable blood pressure insights.

Unilabs operates laboratory, pathology, genetics, and imaging services across 14 markets, employing more than 13,000 people and serving close to 100 million patients annually.